GRANADILLO PEDRO P 4
4 · HAEMONETICS CORP · Filed Sep 19, 2018
Insider Transaction Report
Form 4
GRANADILLO PEDRO P
Director
Transactions
- Exercise/Conversion
Common Stock
2018-09-17$45.45/sh+6,573$298,743→ 48,128 total - Sale
Common Stock
2018-09-17$110.11/sh−3,696$406,967→ 53,283 total - Sale
Common Stock
2018-09-17$113.16/sh−11,812$1,336,646→ 28,288 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2018-09-17−6,573→ 0 totalExercise: $45.45From: 2014-07-24Exp: 2020-07-24→ Common Stock (6,573 underlying) - Exercise/Conversion
Common Stock
2018-09-17$35.50/sh+10,353$367,532→ 58,481 total - Sale
Common Stock
2018-09-17$108.92/sh−1,502$163,598→ 56,979 total - Sale
Common Stock
2018-09-17$111.33/sh−13,183$1,467,663→ 40,100 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2018-09-17−8,196→ 0 totalExercise: $36.37From: 2013-07-27Exp: 2019-07-27→ Common Stock (8,196 underlying) - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2018-09-17−10,353→ 0 totalExercise: $35.50From: 2015-07-23Exp: 2021-07-23→ Common Stock (10,353 underlying) - Sale
Common Stock
2018-09-17$114.16/sh−631$72,035→ 27,657 total - Exercise/Conversion
Common Stock
2018-09-17$36.37/sh+8,196$298,089→ 41,555 total
Footnotes (8)
- [F1]Transaction pursuant to an existing 10b5-1 trading plan.
- [F2]This number includes unvested restricted stock units previously reported.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.61 to $109.33, inclusive. The reporting person undertakes to provide to Haemonetics Corporation ("Haemonetics"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (7) to this Form 4.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.79 to $110.55, inclusive.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.92 to 111.88, inclusive.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.51 to $113.35, inclusive.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114 to $114.44, inclusive.
- [F8]Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.